🇨🇦 Basal insulin glargine and lixisenatide in Canada

Basal insulin glargine and lixisenatide (Basal insulin glargine and lixisenatide) regulatory status in Canada.

Marketing authorisation

Basal insulin glargine and lixisenatide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Basal insulin glargine and lixisenatide approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Basal insulin glargine and lixisenatide in Canada?

LMC Diabetes & Endocrinology Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.